| Literature DB >> 36008498 |
Biao Tang1,2, Weike Zhou3, Xia Wang3, Hulin Wu4, Yanni Xiao5,6.
Abstract
COVID-19 epidemics exhibited multiple waves regionally and globally since 2020. It is important to understand the insight and underlying mechanisms of the multiple waves of COVID-19 epidemics in order to design more efficient non-pharmaceutical interventions (NPIs) and vaccination strategies to prevent future waves. We propose a multi-scale model by linking the behaviour change dynamics to the disease transmission dynamics to investigate the effect of behaviour dynamics on COVID-19 epidemics using game theory. The proposed multi-scale models are calibrated and key parameters related to disease transmission dynamics and behavioural dynamics with/without vaccination are estimated based on COVID-19 epidemic data (daily reported cases and cumulative deaths) and vaccination data. Our modeling results demonstrate that the feedback loop between behaviour changes and COVID-19 transmission dynamics plays an essential role in inducing multiple epidemic waves. We find that the long period of high-prevalence or persistent deterioration of COVID-19 epidemics could drive almost all of the population to change their behaviours and maintain the altered behaviours. However, the effect of behaviour changes fades out gradually along the progress of epidemics. This suggests that it is essential to have not only persistent, but also effective behaviour changes in order to avoid subsequent epidemic waves. In addition, our model also suggests the importance to maintain the effective altered behaviours during the initial stage of vaccination, and to counteract relaxation of NPIs, it requires quick and massive vaccination to avoid future epidemic waves.Entities:
Keywords: Behavioural change; COVID-19 epidemic; Game theory; Multi-scale model; Multiple waves
Mesh:
Year: 2022 PMID: 36008498 PMCID: PMC9409627 DOI: 10.1007/s11538-022-01061-z
Source DB: PubMed Journal: Bull Math Biol ISSN: 0092-8240 Impact factor: 3.871
Fig. 1Schematic diagram for coupling the COVID-19 transmission dynamics and behavioural change dynamics
Parameter definition and estimation
| Values(SD) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Parameters | Definition | Units | Source | |||||
| HK | Japan | USA | Global | |||||
| Transmission rate of symptomatic infected individuals | 1.505 (0.251) | 1.403 (0.052) | 2.025 (0.057) | 1.559 (0.137) | day | Estimated | ||
| Transmission rate of asymptomatic infected individuals | 0.625 (0.19) | 0.226 (0.028) | 0.600 (0.026) | 0.603 (0.051) | day | Estimated | ||
| Constant multiplier factor of the reduction of transmission rate | 0.33 (0.07) | – | – | 0.37 (0.032) | – | Estimated | ||
| Multiplier factor of the reduction of transmission rate in Phase 1 | – | 0.0895 (0.058) | 0.306 (0.01) | – | – | Estimated | ||
| Multiplier factor of the reduction of transmission rate in Phase 2 | – | 0.493 (0.022) | 0.351 (0.008) | – | – | Estimated | ||
| Multiplier factor of the reduction of transmission rate in Phase 3 | – | 0.674 (0.019) | 0.3926 (0.008) | – | – | Estimated | ||
| Transition rate of exposed individuals to the infected class | 1/5.2 | day | CPMA | |||||
| Diagnosis rate of symptomatic infected individuals initially | 0.0048 (0.004) | 0.008 (0.0015) | 0.0079 (0.0008) | 0.0084 (0.001) | day | Estimated | ||
| Exponential increasing rate of the diagnosis rate | 0.2338 (0.212) | 0.4127 (0.1297) | 0.4464 (0.2197) | 0.6553 (0.442) | day | Estimated | ||
| Maximum diagnosis rate of symptomatic infections | 0.739 (0.092) | 0.5243 (0.0242) | 0.399 (0.013) | 0.286 (0.021) | day | Estimated | ||
| Proportion of symptomatic infection | 0.714 (0.077) | 0.752 (0.02) | 0.811 (0.0048) | 0.807 (0.0153) | – | Estimated | ||
| Disease induced death rate in Phase 1 | 0.00013 (0.0003) | 0.0063 (0.0006) | 0.009 (0.0002) | 0.0068 (0.002) | day | Estimated | ||
| Disease induced death rate in Phase 2 | 0.0033 (0.0013) | 0.0014 (0.0001) | 0.0036 (0.0001) | 0.0044 (0.0005) | day | Estimated | ||
| Disease induced death rate in Phase 3 | 0.0014 (0.0017) | 0.0009 (0.00008) | 0.0014 (0.0004) | 0.0019 (0.0002) | day | Estimated | ||
| Recovery rate of infections | 0.195 | day | Tang et al. | |||||
| Recovery rate of asymptomatic infected individuals | 0.139 | day | Tang et al. | |||||
| Recovery rate of confirmed cases | 0.083 (0.029) | 0.0834 (0.0098) | 0.097 (0.0074) | 0.101 (0.016) | day | Estimated | ||
| Constant response rate of perceived infection prevalence on the newly confirmed cases | 0.386 (0.065) | – | – | 0.011 (0.003) | – | Estimated | ||
| Response rate of perceived infection prevalence on the newly confirmed cases in Phase 1 | – | 0.081 (0.009) | 0.0444 (0.003) | – | – | Estimated | ||
| Response rate of perceived infection prevalence on the newly confirmed cases in Phase 2 | – | 0.044 (0.012) | 0.289 (0.027) | – | – | Estimated | ||
| Response rate of perceived infection prevalence on the newly confirmed cases in Phase 3 | – | 0.0851 (0.1906) | 0.4925 (0.0724) | – | – | Estimated | ||
| Decay rate of perceived risk | 0.962 (0.048) | 0.851 (0.013) | 0.850 (0.0004) | 0.657 (0.131) | day | Estimated | ||
| Constant spreading rate of behaviour changes | 0.460 (0.085) | – | – | 0.010 (0.004) | day | Estimated | ||
| Spreading rate of behaviour changes in Phase 1 | – | 0.184 (0.054) | 0.0078 (0.0009) | – | day | Estimated | ||
| Spreading rate of behaviour changes in Phase 2 | – | 0.3962 (0.0523) | 0.016 (0.032) | – | day | Estimated | ||
| Spreading rate of behaviour changes in Phase 3 | – | 0.263(0.28) | 0.059 (0.102) | – | day | Estimated | ||
| 1/ | Threshold for perceived infection | 8.489 (1.273) | 9.571 (0.512) | 15.988 (1.05) | 11.656 (3.528) | – | Estimated | |
Fig. 2COVID-19 epidemic data, including the daily reported cases and accumulative death cases for Hongkong, Japan, USA and the world from the Johns Hopkins University Center for Systems Science and Engineering (JHU CCSE) and the data are available on the Github and the Humanitarian Data Exchange (Github 2021; HDE 2021)
Fig. 3Model fitting results for model (7): The blue curves are the estimated curves with the shadow areas as the corresponding 95% confidence band. The red cycles are the observed data of the daily reported cases and the accumulative death cases
Fig. 4Empirical distributions of the estimated behavioural dynamic parameters by fitting model (7) to the observed epidemic data from Hongkong and the world based on 500 bootstrap samples
Fig. 5Estimated behavioural dynamics: and M(t). The solid curves are the estimated dynamic curves with the shadow areas as the corresponding 95% confidence intervals based on the bootstrap method. The black dash curves are the estimated daily reported cases from model (7)
Fig. 6Solutions of model (7) by fixing all the parameters as constants with . Particularly, in A, in B, in C, and in D. The other parameters and initial conditions are fixed as those of Hongkong listed in Table 1
Fig. 7Evolution of the estimated values of the three key parameters related to behavioural changes in Japan and USA
Fig. 8Simulated daily reported cases based on model (7) with different assumptions of behavioural dynamic parameters. A, B Daily reported cases in USA and Japan under different scenarios by decreasing the values of q in Phases 2 and 3. C–F Daily reported cases in Hongkong by varying the four parameters related to behavioural change dynamics. The subscript ‘e’ indicates the estimated value from the observed data. The values of all other parameters were set as those listed in Table 1
Fig. 9A, B Model fitting results for the vaccination model (model (11)) to the data between December 20th, 2020 to February 14th, 2021 in USA. C The estimated time-varying vaccination coverage in USA. The red cycles are the observed data, the blue curves are the estimated curves with the shadows as the corresponding 95% confidence interval from the bootstrap method
Definitions and estimated values of additional parameters in the vaccination model (11) for USA
| Reduced transmission rate due to behaviour changes since Dec 20, 2020 (Phase 4) | – | 0.3336 (0.0250) | |
| Response rate of perceived infection prevalence on the newly confirmed cases since Dec 20, 2020 | – | 0.2116 (0.2119) | |
| Spreading rate of behaviour changes since Dec 20, 2020 | day | 0.0540 (0.1437) | |
| Decay rate of perceived risk since Dec 20, 2020 | day | 0.7391 (0.2386) | |
| Prevalence threshold since Dec 20, 2020 | – | 218.32 (361.06) | |
| Initial vaccination rate | day | ||
| The increasing rate of the vaccination rate | day | 0.1036 (0.0378) | |
| The maximum vaccination rate | day | 0.0085 (0.0142) |
Fig. 10Simulation and prediction results from the vaccination model (model (11)) for USA. A Two scenarios of the reduced transmission rate due to alternative behaviours (q): one as the estimated values for Phase 4 and another as returning to the higher level of Phase 3 , under the condition with vaccination (the vaccination rate was set as the estimated values for Phase 4, ) and without vaccination (). C and E q increased from February 14th, 2021, where the vaccination rate was set as the estimated value from the data in C and no vaccination was used in E. q increased to 20% higher than that in Phase 3 from February 14th, 2021 and the different vaccination rates were used in B, D and F. The vaccination coverage can reach around 40% till the end of June 2021 under the estimated vaccination rate from the current data, while the coverage could increase to over 60% by tripling the maximum vaccination rate . The subscript ‘e’ indicating the estimated value from the data